Silviavirus phage ɸMR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin

Chanthol Peng,Tomoko Hanawa,Aa Haeruman Azam,Cierra LeBlanc,Porsry Ung,Takeaki Matsuda,Hiroaki Onishi,Kazuhiko Miyanaga,Yasunori Tanji
DOI: https://doi.org/10.1007/s00253-019-10039-2
IF: 5
2019-08-06
Applied Microbiology and Biotechnology
Abstract:The emergence of life-threatening methicillin-resistant <em class="EmphasisTypeItalic">Staphylococcus aureus</em> (MRSA) has led to increased interest in the use of bacteriophages as an alternative therapy to antibiotics. The success of phage therapy is greatly dependent on the selected phage possessing a wide host range. This study describes phage ɸMR003 isolated from sewage influent at a municipal wastewater treatment plant in Tokyo, Japan. ɸMR003 could infect 97% of 104 healthcare- and community-associated MRSA strains tested, compared with 73% for phage ɸSA012, which has a broad host range against bovine mastitis <em class="EmphasisTypeItalic">S. aureus</em>. Genome analysis revealed that ɸMR003 belongs to the genus <em class="EmphasisTypeItalic">Silviavirus</em> which has not been studied extensively. ɸMR003 recognizes and binds to wall teichoic acid (WTA) of <em class="EmphasisTypeItalic">S. aureus</em> during infection. In silico comparisons of the genomes of ɸMR003 and ɸSA012 revealed that ORF117 and ORF119 of ɸMR003 are homologous to the putative receptor-binding proteins ORF103 and ORF105 of ɸSA012, with amino acid similarities of 75% and 72%, respectively. ORF104, which is an <em class="EmphasisTypeItalic">N</em>-acetylglucosaminidase found in the ɸMR003 tail, may facilitate phage's infection onto the WTA-null <em class="EmphasisTypeItalic">S. aureus</em> RN4220. The differences in tail and baseplate proteins may be key contributing factors to the different host specificities of ɸMR003 and ɸSA012. ɸMR003 showed strong adsorptivity, but not infectivity, against <em class="EmphasisTypeItalic">S. aureus</em> SA003, which may be influenced by the bacterium's restriction modification system. This study expands our knowledge of the genomic diversity and host specificity of <em class="EmphasisTypeItalic">Silviavirus</em>, which is a potential phage therapy candidate for MRSA infections.
biotechnology & applied microbiology
What problem does this paper attempt to address?